About US
Contact us
-
Fujifilm starts build-out for massive NC plant, the latest piece of its multibillion-dollar CDMO expansion effortEarlier this month, when Fujifilm Diosynth broke ground in North Carolina on a facility destined to become its showcase, the occasion was more about the company than the plant. While the2021/10/27
-
Is Sandoz spinoff finally here? Novartis gets the ball rolling with strategic reviewWhen Novartis unveiled a plan in 2018 to grant its Sandoz generics business more autonomy, industry watchers read spinoff. Now, a separation may be around the corner. Novartis haslauncheda strateg2021/10/27
-
What would Medicare price negotiations bring to the US? Look to Europe, Lilly CEO Ricks saysWhen posed with the decades-old question of how drug price reform would affect theiroperations in the U.S., pharma execs have a ready-made response: Reducing drug prices would hinder innovation.2021/10/25
-
Novartis looks for silver lining in $2B canakinumab repurposing after 2nd lung cancer failureIs autoinflammatory disease treatment Ilaris a potential new therapy for non-small cell lung cancer (NSCLC)? After two pivotal trial failures, the answer seems to be no; but Novartis is still seeing2021/10/22
-
Revance's Botox rival turned away by FDA after inspectors flagged manufacturing 'deficiencies'Despite a pandemic delay and an FDA warning about quality control and record-keeping problems at a production site, Revance insisted it was optimistic the agency would approve its would-be Botox riva2021/10/20
-
Roche ushers early lung cancer into immunotherapy era with Tecentriq FDA approval. Will doctors follow?Roche’s Tecentriq has ushered in a new era, offering the firstimmunotherapy option fornon-small cell lung cancer (NSCLC) patients right after tumor surgery. But doctors appear reluctant to use it for2021/10/18
-
The energy switch: Big Pharma harnesses sun, wind and water in quest for a low-carbon futureAlongside collaborative robots and automated guided vehicles, Amgen has carved out space for solar panels at its upcoming smart factory in New Albany, Ohio. The company’s $550 million facility-to-be2021/10/18
-
Johnson & Johnson wins FDA panel backing for a second dose of its COVID shot but don’t call it a ‘booster’Over the last year, the Johnson & Johnson COVID-19 vaccine has been commonly referred to as a single-shot alternative to the two-dose regimens of mRNA vaccines from Pfizer-BioNTech and Moderna. B2021/10/15
-
Amgen's latest Lumakras data in KRAS cancer underscore the bumpy road for combo strategy: analystWith Lumakras the first drug specifically approved for KRAS-mutated cancer, Amgen is examining various combination options to expand its reach. But new data underline the difficulty in finding the ri2021/10/13
-
Sanofi, GSK, Pfizer and Boehringer must face Zantac class-action lawsuits, court rulesEven after the global Zantac recalls of 2019 and 2020 and the associated controversy, the courtroom saga over the medicine's risk is just getting started. This week, branded drugmakers GlaxoSmithKlin2021/10/13